Gsa Capital Partners LLP Revolution Medicines, Inc. Transaction History

Gsa Capital Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$30.14 - $40.68 $713,293 - $962,732	23,666 Added 303.37%	31,467 $1.22 Million
Q1 2024 May 03, 2024	BUY	$26.56 - $33.55 $207,194 - $261,723	7,801 New	7,801 $251,000
Q2 2023 Aug 14, 2023	SELL	$20.28 - $27.0 $417,666 - $556,065	-20,595 Reduced 52.33%	18,762 $501,000
Q1 2023 May 12, 2023	BUY	$20.76 - $30.09 $817,051 - $1.18 Million	39,357 New	39,357 $852,000
Q2 2022 Aug 09, 2022	BUY	$14.54 - $27.17 $613,355 - $1.15 Million	42,184 New	42,184 $822,000

266

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.